New to the Fed, Miran Defends Calls for Sharper Reduction in Interest Rates
In his first comments since joining the Federal Reserve Board, Stephen Miran sought to emphasize his independence from the White House. Read more
Read MoreFDA OKs New Keytruda Shot for Cancer
The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars. Read more
Read More
‘Tax the Rich,’ French Protesters Cry, as the Wealthy Push Back on Paying More
With a budget crisis looming, a proposal for a tax on ultrahigh-wealth individuals has grass-roots support, but it adds conflict to an already fragmented political landscape. Read more
Read More